BioXcel Therapeutics
BTAI
BTAI
20 hedge funds and large institutions have $24.9M invested in BioXcel Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$925K | |
| 2 | +$481K | |
| 3 | +$345K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$235K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$195K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$153K | |
| 3 | -$19K | |
| 4 |
Morgan Stanley
New York
|
-$12.9K |
| 5 |
BlackRock
New York
|
-$7.64K |